> Pathway Inhibitors>TAK-931

Pathway Inhibitors

TAK-981 View larger

TAK-931

AOB17360

CAS: 1330782-76-7

 

Chemical Name: Simurosertib; 2-[(2S)-1-Azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)-1H-thieno[3,2-d]pyrimidin-4-one

More details

Molarity Calculation Cart®

HOW TO ORDER

$59.00

$59.00 per mg

Add to my wishlist

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $26.55 Total: $2,655.00
150 $30.68 Total: $1,534.00
125 $35.99 Total: $899.75
110 $42.48 Total: $424.80
15 $50.15 Total: $250.75

Data sheet

Molecular FormulaC17H19N5OS
Molecular Weight341.43
CAS Numbers1858276-04-6
Storage Condition0°C (short term), -20°C (long term), desiccated
SolubilityDMSO
Purity98% by HPLC
SynonymTAK-931; TAK 931; TAK931; Simurosertib.
IUPAC/Chemical NameThieno(3,2-d)pyrimidin-4(3H)-one, 2-(2S)-1-azabicyclo(2.2.2)oct-2-yl-6-(3-methyl-1H-pyrazol-4-yl)-
InChl KeyXGVXKJKTISMIOW-ZDUSSCGKSA-N
InChl CodeInChI=1S/C17H19N5OS/c1-9-11(8-18-21-9)14-7-12-15(24-14)17(23)20-16(19-12)13-6-10-2-4-22(13)5-3-10/h7-8,10,13H,2-6H2,1H3,(H,18,21)(H,19,20,23)/t13-/m0/s1
SMILES CodeO=C1C2=C(C=C(C3=CNN=C3C)S2)N=C([C@H]4N(CC5)CCC5C4)N1
References1) Kurasawa O, et al., Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent. J Med Chem. 2020 Jan 2. doi: 10.1021/acs.jmedchem.9b01427. [Epub ahead of print] PubMed PMID: 31895562.

More info

Novel potent and selective cycle 7 (CDC7) kinase inhibitor